Factorytalk is proud to join the ISPE Indonesia Annual Conference 2026, taking place on 12–13 May 2026 at the Aston Kartika Hotel & Conference Center Jakarta. Under the theme “Collaboration and Sustainability are Key Success Factors for Future Pharma Industry,” this year’s event brings together industry leaders shaping the next phase of pharmaceutical manufacturing.
A key highlight: Factorytalk has been invited to speak in the plenary session.
Artificial Intelligence is no longer a future concept—it’s already transforming pharmaceutical manufacturing. In this session, David will explore how AI is being applied across the value chain, from supply chain planning and warehousing to production, quality assurance, and regulatory submissions.
You’ll gain insight into:
- How technologies like machine learning, computer vision, copilots, and AI agents are delivering measurable results—reducing false rejects, increasing yields, and accelerating decision-making
- The evolving regulatory landscape, including guidance from US FDA, EMA, EU AI Act, and draft EU GMP Annex 22
- Practical frameworks from ISPE GAMP AI Community of Practice for implementing AI responsibly in GxP environments
- Key principles for success: human oversight, validated controls, secure data governance, and modern digital plant architectures
📍 Building on these insights, we invite you to continue the conversation at Tabletop No. 21.
Here, the Factorytalk team will demonstrate how digital transformation come together across a connected GxP ecosystem—including:
- BatchLine MES & Electronic Batch Records (EBR) for paperless manufacturing
- eQMS solutions to streamline quality and enable closed-loop operations
- Frontline operations platforms (no-code/low-code) to digitise shopfloor processes
- CSV and GxP consulting services to ensure compliance and validation readiness
- Regulatory e-submission solutions to simplify and accelerate submissions
Whether you’re starting your digital journey or scaling AI across your operations,
visit us to explore practical, compliant, and scalable approaches tailored for life sciences manufacturing.
